StartupHistory

An open directory of startups through time

Public records · dated sources
Free to read. Free to reuse.

Company records / invasight.com

Invasight

Invasight (invasight.com): no confident changes recorded yet; website history since June 2021.

The website did not answer the latest live check. Last tried 6 November 2026.

First recorded website

Observed 23 June 2021

Our earliest capture with readable facts. This is our first observation, not when the company introduced these things. These website claims are not independently verified.

How it described itself

Invasight- Home

First-in-class, protein-protein interaction inhibitors against invasive cancers.

All facts above belong to this capture. Unlisted fields mean we have no readable observation, not that they were absent.

Recorded changes

Newest observations first. Each interval bounds when the website changed; it is not an exact event date.

No changes recorded yet. Missing observations do not mean the company has not changed.

How it describes itself

Similar headlines are grouped together. The quote shown is from the last capture in each group, not necessarily the exact wording throughout that period.

  1. January 2023 – July 2025 · 5 captures · latest observed messagingAdvanced targeted therapies for invasive cancers

    This is an example page. It’s different from a blog post because it will stay in one place and will show up in your site navigation (in most themes). Most people start with an About page that introduc

    This wording observed 24 July 2025.

    Inspect 5 captures in this group
    • 19 January 2023 · Advanced targeted therapies for invasive cancers archived page
    • 26 September 2023 · Advanced targeted therapies for invasive cancers archived page
    • 4 January 2024 · Advanced targeted therapies for invasive cancers archived page
    • 5 August 2024 · Advanced targeted therapies for invasive cancers archived page
    • 24 July 2025 · Advanced targeted therapies for invasive cancers archived page
  2. June 2021 – July 2022 · 3 capturesInvasight- Home

    First-in-class, protein-protein interaction inhibitors against invasive cancers.

    This wording observed 11 July 2022.

    Inspect 3 captures in this group

Cite this record

StartupHistory, “Invasight” company record, https://startuphistory.org/c/invasight.com

Machine-readable: /c/invasight.com.json. How changes are found: method.